Hand-Foot syndrome induced by sorafenib, a multitargeted tyrosine kinase inhibitor, in a patient with advanced renal cell carcinoma
![]() |
Lee, Seung Hyun
(Department of Pediatrics, Research Institute of Clinical Medicine School of Medicine, Chonbuk National University)
Noh, Sung Hun (Department of Pediatrics, Research Institute of Clinical Medicine School of Medicine, Chonbuk National University) Kim, Sun Young (Department of Pediatrics, Research Institute of Clinical Medicine School of Medicine, Chonbuk National University) Jang, Kyu Yun (Department of Pathology, Research Institute of Clinical Medicine School of Medicine, Chonbuk National University) Hwang, Pyoung Han (Department of Pediatrics, Research Institute of Clinical Medicine School of Medicine, Chonbuk National University) |
1 | Flanigan RC, Campbell SC, Clark JI, Picken MM. Metastatic renal cell carcinoma. Curr Treat Options Oncol 2003;4:385-90 DOI ScienceOn |
2 | Lokich JJ, Moore C. Chemotherapy-associated palmar-plantar erythroydysesthesia syndrome. Ann Intern Med 1984;101: 798-800 PUBMED ScienceOn |
3 | Banfield GK, Crate ID, Griffiths CL. Long-term sequelae of palmar-plantar erythrodysaesthesia syndrome secondary to 5-fluorouracil therapy. JR Soc Med 1995;88:356-7 ScienceOn |
4 | Kara IO, Sahin B, Erkisi M. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction. Breast 2006;15:414-24 DOI PUBMED ScienceOn |
5 | Drake RD, Lin WM, King M, Farrar D, Miller DS, Coleman RL. Oral dexamethasone attenuates Doxil-induced palmar- plantar erythrodysesthesias in patients with recurrent gynecologic malignancies. Gynecol Oncol 2004;94:320-4 DOI ScienceOn |
6 | Kumar S, Carr T, Marsden HB, Morris-Jones PH. Study of childhood renal tumors using peroxidase conjugated lectins. J Clin Pathol 1986;39:736-41 DOI PUBMED |
7 | Fabian CJ, Molina R, Slavik M, Dahlberg S, Giri S, Stephens R. Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs 1990;8:57-63 DOI PUBMED |
8 | Babhulkar SS, Pande K, Babhulkar S. The hand-foot syndrome in sickle cell haemoglobinopathy. J Bone Joint Surg Br 1995;77:310-2 |
9 | Lassere Y, Hoff P. Management of hand-foot syndrome in patients treated with capecitabine. Eur J Oncol Nurs 2004;8: 531-40 DOI |
10 | Mrozek-Orlowski ME, Frye DK, Sanborn HM. Capecitabine: nursing implications of a new oral chemotherapeutic agent. Oncol Nurs Forum 1999;26:753-62 PUBMED ScienceOn |
11 | Lopez AM, Wallace L, Dorr RT, Koff M, Hersh EM, Alberts DS. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia. Cancer Chemother Pharmacol 1999;44:303-6 DOI ScienceOn |
12 | Zhao WP, Gnarra JR, Liu S. Renal cell carcinoma: Cytogenetic analysis of tumors and cell lines. Cancer Genet Cytogenet 1995;82:128-39 DOI ScienceOn |
13 | Abushullaih S, Saad ED, Munsell M, Hoff PM. Incidence and severity of HFS in colorectal cancer patients treated with capecitabine: a single-institution experience. Cancer Investigation 2002;20:3-10 DOI ScienceOn |
14 | Gerbrecht BM. Current Canadian experience with capecitabine. Cancer Nursing 2003;26;161-7 DOI PUBMED ScienceOn |
15 | Chin SF, Tchen N, Oza AM, Moore MJ, Warr D, Siu LL. Use of "bag balm" as topical treatment of palmar plantar erythrodysesthesia syndrome in patients receiving selected chemotherapeutic agents. Proceedings of the American Society of Clinical Oncology 2001 May 12-15; San Francisco, CA. (abstract 1632) |
16 | Hahn O, Stadler W. Sorafenib. Curr Opin Oncol 2006;18: 615-21 DOI ScienceOn |
17 | Lee SD, Kim HJ, Hwang SJ, Kim YJ, Nam SH, Kim BS. Hand-Foot Syndrome with Scleroderma-like Change Induced by the Oral Capecitabine: A Case Report. Korean J Intern Med. 2007;22:109-112 DOI ScienceOn |
18 | Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, et al. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 2002;13:566-75 DOI ScienceOn |
19 | Morabito A. Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: Current status and future directions. Oncologist 2006;11:753-64 DOI ScienceOn |
20 | Indolfi P, Terenziani M, Casale F, Carli M, Bisogno G, Schiavetti A, et al. Renal cell carcinoma in children: a clinicopathologic study. J Clin Oncol 2003;21:530-5 DOI ScienceOn |
![]() |